MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.athoracsur.2024.01.017

Медицинская библиотека · The Annals of thoracic surgery · 2024

Mechanical Circulatory Support During Surgical Revascularization for Ischemic Cardiomyopathy.

Singh Sameer K, Vinogradsky Alice, Kirschner Michael, Sun Jocelyn, Wang Chunhui, Kurlansky Paul, Kaku Yuji, Smith Craig R, Takeda Koji

СтатьяПеревод в очереди

Аннотация

BACKGROUND

This study aimed to describe the use of perioperative mechanical circulatory support (MCS) and its impact on outcomes in patients with ischemic cardiomyopathy who were undergoing surgical revascularization.

METHODS

Patients with an ejection fraction <35% who underwent isolated coronary artery bypass grafting (CABG) from 2015 to 2021 were identified (N = 378). Patients were divided into no MCS, preoperative MCS, and postoperative MCS groups on the basis of timing of MCS initiation, which included intraaortic balloon pump, extracorporeal membrane oxygenation, or Impella device (Abiomed) use. The primary outcome of interest was operative mortality.

RESULTS

The median Society of Thoracic Surgeons Predicted Risk of Mortality was 2.4%. Sixty-six percent (n = 246) of patients had a previous myocardial infarction, and 61.8% of these patients were within 21 days of CABG. Twenty-one patients (5.6%) presented in cardiogenic shock. The preoperative MCS cohort consisted of 31 patients (8.2%) who underwent CABG a median of 2 days after MCS initiation. Thirty (7.9%) patients required postoperative MCS. Independent risk factors for requiring postoperative MCS included the preoperative ejection fraction (odds ratio, 0.93; P = .01 and the presence of preoperative MCS (odds ratio, 3.06; P = .02). Overall, operative mortality was 3.4%, and 3-year survival was 87.0%. Operative mortality in patients who did and did not receive preoperative MCS was 7.7% and 2.9% (P = .12) with no difference in long-term survival (P = .80), whereas patients requiring postoperative MCS had significantly increased operative (16.7%) and late mortality (63%; P <.01).

CONCLUSIONS

CABG can be performed safely in patients with ischemic cardiomyopathy with selective use of perioperative MCS. Despite advanced disease severity, patients requiring preoperative MCS demonstrate acceptable short- and long-term survival. Patients requiring postoperative MCS have increased postoperative morbidity and mortality.

Для цитирования: Singh Sameer K, Vinogradsky Alice, Kirschner Michael, Sun Jocelyn, Wang Chunhui, Kurlansky Paul, Kaku Yuji, Smith Craig R, Takeda Koji. Mechanical Circulatory Support During Surgical Revascularization for Ischemic Cardiomyopathy.. The Annals of thoracic surgery. 2024. DOI: 10.1016/j.athoracsur.2024.01.017.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.